1,983
Views
7
CrossRef citations to date
0
Altmetric
Editorial

‘Charting a new course for prostate cancer’ – currying favor for docetaxel in hormone-sensitive metastatic prostate cancer

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vittore Cereda, Vincenzo Formica, Antonello Menghi, Stefania Pellicori & Mario Roselli. (2015) Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges. Expert Opinion on Investigational Drugs 24:7, pages 929-947.
Read now
Hiten RH Patel. (2014) Foreword. Expert Review of Anticancer Therapy 14:11, pages 1251-1252.
Read now

Articles from other publishers (5)

Hannes Cash, Ursula Steiner, Axel Heidenreich, Theodor Klotz, Peter Albers, Sebastian Melchior, Peter Martus, Florian Fuller, Ahmed Magheli, Stefan Hinz, Carsten Kempkensteffen & Kurt Miller. (2018) Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE). BJU International 122:5, pages 774-782.
Crossref
Neil Harvey, Adebanji Adeyoju & Richard Brough. 2017. Cancer in Sub-Saharan Africa. Cancer in Sub-Saharan Africa 95 107 .
K.D. Tew. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Arndt Katzenwadel & Philipp Wolf. (2015) Androgen deprivation of prostate cancer: Leading to a therapeutic dead end. Cancer Letters 367:1, pages 12-17.
Crossref
Judd W. Moul. (2015) High-risk prostate cancer and radical prostatectomy in the setting and context of multidisciplinary care. Urologic Oncology: Seminars and Original Investigations 33:5, pages 206-207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.